HK$ 13.43
Key Takeaways
Risk factor
Very vulnerable to price shocks
Profitability factor
Strong margins and returns
About
China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. The company's products include Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu for the treatment of acute heart failure; Deanxit for the treating mild-to-moderate depression, anxiety, and psychosomatic affections; Ursofalk...
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. In particular, the stock is reasonably priced on P/E, of fair val
Target Price
The average target price of 0867.HK is 15 and suggests 15% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation
